SanaCurrents Closing out ChemoCentryx and Rhythm
ChemoCentryx (NASDAQ:CCXI) and Rhythm Pharmaceuticals (NASDAQ:RYTM) released positive but mixed [...]
ChemoCentryx (NASDAQ:CCXI) and Rhythm Pharmaceuticals (NASDAQ:RYTM) released positive but mixed [...]
After the markets closed on Thursday, December 3, BioCryst Pharmaceuticals [...]
Clinical data findings related to five SanaCurrents catalysts will be [...]
The FDA will decide on December 3 whether to approve [...]
Adverum Biotechnologies (NASDAQ:ADVM) on Saturday reported positive results from its [...]
Adverum Biotechnologies (NASDAQ:ADVM) said it will present additional clinical data [...]
Sweden-based Calliditas Therapeutics’ (NASDAQ:CALT) delivered on its phase III trial [...]
In an earnings release after the market closed on November [...]